2026 NPPES data Corneal and Contact Management Optometrist NPI 1639190150 O.D.
Verify on CMS →

HERMINDER BOPARAI, O.D.

Corneal and Contact Management Optometrist in BELLEVUE, Washington. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
890
Medicare Part D claims · 218 beneficiaries · Corneal and Contact Management Optometrist avg: 235
Generic prescribing
48%
generic claims · 52% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · [object Object]
Industry payments
$54.8K
154 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

HERMINDER BOPARAI, O.D. reported a CMS MIPS final score of 75/100 — below the 83.1 national average — and filed 890 Medicare Part D claims in 2023.

75/100
MIPS score · -8 vs avg
890
Part D claims, 2023
48%
generic prescribing
$54.8K
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

HERMINDER BOPARAI, O.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

75 15th percentile higher than 15% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

What does the federal data show about HERMINDER BOPARAI, O.D.?

Below national average

NPI registry status

Active

Issued 07/21/2006

NPI 1639190150

Primary specialty

Corneal and Contact Management Optometrist

Niche

1,549 US NPIs in this specialty

Medicare Part D claims

890 279% vs specialty avg

2023 prescription claims

Specialty avg: 235

MIPS final score

75/100 8.099999999999994% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Washington

How Corneal and Contact Management Optometrist compares to other specialties among Washington providers

Washington providers

Corneal and Contact Management Optometrist share within Washington

1. Corneal and Contact Management Optometrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Corneal and Contact Management Optometrist share within Washington

Medicare quality performance — MIPS

HERMINDER BOPARAI, O.D.'s 2023 MIPS final score plotted against the Corneal and Contact Management Optometrist national average

Below national average
MIPS Final Score
75/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Corneal and Contact Management Optometrist) — 75/100 vs national avg 83.1

0%100%National avg83%75%
MIPS final score (Corneal and Contact Management Optometrist) — 75/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

HERMINDER BOPARAI, O.D. appears in the CMS NPPES registry as a Corneal and Contact Management Optometrist provider holding O.D. credentials at 1414 116TH AVE NE STE B, BELLEVUE, WA, 98004, with a listed phone of (425) 502-7922. NPI 1639190150 was issued on 07/21/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BOPARAI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 890 prescription claims written by this provider, covering 218 Medicare beneficiaries and totaling roughly $260K in drug spend, split 52% brand-name and 48% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.

Corneal and Contact Management Optometrist is a narrow specialty nationwide, with 1,549 enrolled providers across 52 states and an average of 235 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1414 116TH AVE NE STE B
BELLEVUE, WA 98004

Provider Details

NPI 1639190150
Specialty Corneal and Contact Management Optometrist
Credentials O.D.
Gender Male
NPI Issued 07/21/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
Avg: 83.1

Reporting: Group practice

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for HERMINDER BOPARAI, O.D.. Source: openpaymentsdata.cms.gov.

Total received

$54.8K

Largest payer

Mallinckrodt Hospital Products Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Washington WMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 — they are NOT specific to HERMINDER BOPARAI, O.D.. To verify HERMINDER BOPARAI, O.D.'s current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

88
Total board actions, Washington 2023
Across 85 cases
2.59
Actions per 1,000 licensees
Washington statewide rate
probation
Most common action type
31 cases

WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

HERMINDER BOPARAI, O.D. — brand share 52.0%
Specialty average (est.)

52% brand-name claims vs 48% generic, on 890 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

890
Total Claims
$260K
Total Drug Cost
218
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,394
Total Day Supply
39,210
Brand vs Generic
52% brand / 48% generic
Brand Drug Cost
$248K
Generic Drug Cost
$13K
Antibiotic Claims
27

Patient Demographics

Average Patient Age
77.7 years
Avg HCC Risk Score
1.09
Gender Split
63% female / 37% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What HERMINDER BOPARAI, O.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Latanoprost
251
Restasis
Cyclosporine
95
Timolol Maleate
91
Xiidra
Lifitegrast
63
Prednisolone Acetate
40
Lumigan
Bimatoprost
39
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
33
Vyzulta
Latanoprostene Bunod
30
Tobramycin-Dexamethasone
Tobramycin/Dexamethasone
28
Cyclosporine
19

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Corneal and Contact Management Optometrist Overview

How HERMINDER BOPARAI, O.D. fits within the Corneal and Contact Management Optometrist landscape nationally.

1,549
Corneal and Contact Management Optometrist Providers in US
52
States with Corneal and Contact Management Optometrist
235
Avg Claims per Provider

HERMINDER BOPARAI, O.D.'s 890 claims are above the specialty average of 235.

Nearby Corneal and Contact Management Optometrist Providers in Washington

Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as BOPARAI.

Compare Corneal and Contact Management Optometrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is HERMINDER BOPARAI, O.D.'s specialty?
HERMINDER BOPARAI, O.D. specializes in Corneal and Contact Management Optometrist and practices in BELLEVUE, Washington. Credentials: O.D..
How much does HERMINDER BOPARAI, O.D. prescribe under Medicare Part D?
In 2023, HERMINDER BOPARAI, O.D. wrote 890 Medicare Part D claims totaling $260K in drug costs for 218 beneficiaries.
What is HERMINDER BOPARAI, O.D.'s Medicare quality score?
HERMINDER BOPARAI, O.D. has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is HERMINDER BOPARAI, O.D. located?
HERMINDER BOPARAI, O.D. is located at 1414 116TH AVE NE STE B, BELLEVUE, WA, 98004. Phone: (425) 502-7922.
What is HERMINDER BOPARAI, O.D.'s NPI number?
HERMINDER BOPARAI, O.D.'s National Provider Identifier (NPI) is 1639190150, issued on 07/21/2006.
Does HERMINDER BOPARAI, O.D. prescribe more brand-name or generic drugs?
HERMINDER BOPARAI, O.D.'s prescribing is 52% brand-name and 48% generic drugs by claim count, with $248K in brand drug costs.
How many Corneal and Contact Management Optometrist providers are there in the US?
There are 1,549 Corneal and Contact Management Optometrist providers across 52 states in the US. The average Corneal and Contact Management Optometrist provider writes 235 Medicare Part D claims per year.
What drugs does HERMINDER BOPARAI, O.D. prescribe most often?
Based on 2023 Medicare Part D data, HERMINDER BOPARAI, O.D.'s most frequently prescribed drugs include Latanoprost, Restasis, Timolol Maleate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does HERMINDER BOPARAI, O.D. accept Medicare?
HERMINDER BOPARAI, O.D. appears in CMS Medicare data with 890 Part D claims and 218 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify HERMINDER BOPARAI, O.D.'s credentials?
HERMINDER BOPARAI, O.D.'s NPI is 1639190150 with credentials O.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology